Key facts
- Axsome Therapeutics director Mark Coleman sold $4.02 million in stock.
- The transaction involved the sale of company shares by a key figure within Axsome Therapeutics.
Axsome Therapeutics director Mark Coleman has sold $4.02 million worth of the company's stock. This significant transaction represents a sale of shares by an individual holding a key position within Axsome Therapeutics. The details of the sale highlight insider activity within the pharmaceutical company.
